• Sign up
  • Login

Scheme Profile

SBI Healthcare Opportunities Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
5,400
Inception Date
31-12-2004
Category
Equity - Sectoral

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 527.3415 (31-Aug-2026) / 402.1148 (21-Jan-2026)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 521.51 ( 2.30) ( 0.44 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Tanmaya Desai
  • Value of () 1,00,000 since inception
  • 23,60,856
  • Entry Load
  • NIL
  • Exit Load
  • 0.50% - If redeemed/switched out wihin 15 days from the date of allotment. Nil - If redeemed/switched out after 15 days from the date of allotment.
  • Expense Ratio (%)
  • 2.00
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 69.37 times
  • Portfolio P/B
  • 9.56 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.35

Risk Factors

  • Jenson's Alpha
  • 16.36
  • Standard Deviation
  • 4.16
  • Beta
  • 0.64
  • Sharpe
  • 1.20
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.14

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Jul 2026 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 34,50,000
  • 12.72
  • Divis Laboratories Ltd
  • Equity
  • 5,00,000
  • 7.46
  • Acutaas Chemicals Ltd
  • Equity
  • 9,00,000
  • 5.17
  • Cipla Ltd
  • Equity
  • 18,60,000
  • 5.07
  • Apollo Hospitals Enterprise Ltd
  • Equity
  • 3,00,000
  • 4.98

Sector Top 5 Holdings

  [ As on 31 Jul 2026 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 2,15,00,000
  • 65.74
  • Healthcare
  • 1,72,28,383
  • 29.68
  • Chemicals
  • 21,60,000
  • 4.58

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 23.88 1.49 - -10.63 5,399.88
2025 -3.78 6.46 - 8.55 3,989.42
2024 41.92 18.51 10.35 8.12 3,628.03
2023 38.25 25.15 38.35 18.10 2,263.22
2022 -5.78 1.23 -11.31 2.80 1,660.46
2021 19.03 23.27 20.57 21.69 1,942.51
2020 65.28 27.28 62.19 15.60 1,575.33
2019 -0.63 7.39 -3.06 13.79 926.47
2018 -9.90 2.53 -5.45 6.67 1,045.43
2017 1.49 29.63 0.53 28.06 1,132.62

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Jun-2026 18.72 10.73 - 0 4,997.72
Mar-2026 -1.23 -14.34 - 0 4,063.64
Dec-2025 -0.58 5.97 - 0 3,989.42
Sep-2025 -2.67 -4.00 - 0 3,933.26

Peer Comparison

<< < 12345> >> 

Asset Allocation

Sector Allocation

Quick links

Close